Stage II Small Lymphocytic Lymphoma

7 clinical trials · Condition

Record	Firm	Date
Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas (NCT02213913)	University of Chicago	2014-07-29
Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT01076556)	National Cancer Institute (NCI)	2010-04-01
Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT01024010)	Mayo Clinic	2010-03-01
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00918723)	Fred Hutchinson Cancer Center	2009-06-01
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery (NCT00608361)	National Cancer Institute (NCI)	2008-10-01
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer (NCT00105001)	Fred Hutchinson Cancer Center	2004-11-01

Every clearance here is in the API, with alerts when new ones post.